PCB launches CAS appeal against Akmal's reduced ban for anti-corruption breach
The PCB said the decision to file an appeal was made following a review of the independent adjudicator's order
The Pakistan Cricket Board (PCB) on Monday said that it will appeal to the Court of Arbitration for Sport (CAS) against the reduction of batsman Umar Akmal's ban for an anti-corruption breach.
The middle-order batsman was banned in April for failing to report approaches to engage in corrupt practices ahead of this year's Pakistan Super League Twenty20 competition.
An independent adjudicator last month reduced Akmal's three-year ban to 18 months, saying Akmal's confession that he failed to report match-fixing approaches on two occasions had left "no room for doubt as to the veracity of the charges".
The PCB said the decision to file an appeal was made following a review of the independent adjudicator's order, which said the ban was reduced "on grounds of taking a compassionate view".
"The PCB doesn't take any pride in seeing a cricketer of Umar's stature being banned for corruption, but as a credible and respectable institution, we need to send out a loud and clear message to all our stakeholders that there will be no sympathy whatsoever for anyone who breaches the regulations," the board said in a statement.
Akmal's 18-month ban had been backdated to Feb. 20 when he was provisionally suspended and the 30-year-old will be eligible to play from August 2021.
He last played for Pakistan in a Twenty20 International against Sri Lanka in Lahore last year.
The 22-year-old Belarusian will rise to a career high ranking of... READ MORE
Couple say they want to protect the privacy of their child. READ MORE
Prime Minister of Pakistan logged 47.3 per cent votes while Indian... READ MORE
He returned to competitive cricket for the first time in seven years... READ MORE
Dr Nawal noted that mutations are common in SARS-CoV-2 — an RNA ... READ MORE
The UAE's vaccine administration rates are just second behind Israel... READ MORE
Experts studying the data from clinical trials say volunteers who had ... READ MORE
More than 23 million tests have been carried out across the country... READ MORE